LRI Investments LLC Lowers Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

LRI Investments LLC cut its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.6% during the fourth quarter, HoldingsChannel reports. The fund owned 1,330 shares of the medical equipment provider’s stock after selling 49 shares during the quarter. LRI Investments LLC’s holdings in Intuitive Surgical were worth $694,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in the stock. Atala Financial Inc purchased a new stake in shares of Intuitive Surgical during the fourth quarter worth about $25,000. Hurley Capital LLC purchased a new position in shares of Intuitive Surgical in the fourth quarter worth $28,000. Berbice Capital Management LLC purchased a new stake in shares of Intuitive Surgical during the fourth quarter valued at $26,000. Parvin Asset Management LLC acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at $26,000. Finally, BankPlus Trust Department purchased a new position in Intuitive Surgical in the 4th quarter worth $28,000. 83.64% of the stock is owned by institutional investors.

Insider Activity at Intuitive Surgical

In related news, VP Fredrik Widman sold 810 shares of the company’s stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $573.78, for a total transaction of $464,761.80. Following the completion of the sale, the vice president now owns 473 shares of the company’s stock, valued at approximately $271,397.94. This represents a 63.13% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Brian Edward Miller sold 8,900 shares of the stock in a transaction dated Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the completion of the sale, the executive vice president now owns 5,758 shares of the company’s stock, valued at approximately $2,793,033.06. The trade was a 60.72% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 33,044 shares of company stock valued at $17,070,433. 0.70% of the stock is owned by insiders.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on ISRG. Royal Bank of Canada cut their price objective on Intuitive Surgical from $630.00 to $605.00 and set an “outperform” rating on the stock in a report on Wednesday, April 23rd. Leerink Partners upped their price objective on shares of Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. BTIG Research set a $560.00 target price on shares of Intuitive Surgical and gave the stock a “buy” rating in a report on Monday, April 14th. JPMorgan Chase & Co. increased their price target on Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Finally, Evercore ISI decreased their price objective on Intuitive Surgical from $510.00 to $470.00 and set an “in-line” rating for the company in a report on Wednesday, April 23rd. Five analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $598.95.

Intuitive Surgical Trading Down 0.3%

Shares of Intuitive Surgical stock opened at $536.55 on Monday. Intuitive Surgical, Inc. has a twelve month low of $379.67 and a twelve month high of $616.00. The firm has a market capitalization of $192.31 billion, a PE ratio of 83.71, a P/E/G ratio of 5.85 and a beta of 1.70. The firm’s 50-day moving average price is $500.93 and its 200 day moving average price is $535.03.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating the consensus estimate of $1.71 by $0.10. The business had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.19 billion. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. During the same quarter last year, the business posted $1.50 earnings per share. On average, sell-side analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.